CFG:NYSECitizens Financial Group, Inc. Analysis
Data as of 2026-03-10 - not real-time
$59.11
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Citizens Financial Group is trading at roughly $59, well below its DCF‑derived fair value of $81, giving an upside potential of over 20% and positioning the stock as materially undervalued. The 20‑day and 50‑day SMAs sit just above the current price, while the 200‑day SMA at $52.9 provides a strong long‑term support base. Technical momentum is mixed: the RSI of 39 suggests the shares are approaching oversold territory, yet the MACD histogram remains negative, indicating short‑term bearish pressure. Volume is on an increasing trend, reinforcing the bullish trend direction noted in the quantitative data. Fundamentals show a solid operating margin of 32% and a forward PE of 9.4, underscoring earnings growth potential. Dividend sustainability looks robust with a 3.16% yield and a payout ratio under 45%, supported by ample cash reserves. Analyst sentiment is overwhelmingly positive, with a “strong_buy” recommendation from 20 analysts and a recent upgrade by Morgan Stanley to an $80 target. The bank’s regional exposure limits geographic concentration risk, though regulatory scrutiny typical of the banking sector remains a factor. Overall, the combination of valuation gap, dividend appeal, and improving earnings makes CFG an attractive entry point for investors seeking both income and capital appreciation.
Given the current support at $55.8 and the upside to the $68.8 resistance zone, a disciplined buy‑on‑dip strategy aligns with the technical and fundamental backdrop, while maintaining vigilance on short‑term MACD weakness and broader banking sector dynamics.
Given the current support at $55.8 and the upside to the $68.8 resistance zone, a disciplined buy‑on‑dip strategy aligns with the technical and fundamental backdrop, while maintaining vigilance on short‑term MACD weakness and broader banking sector dynamics.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near strong support level
- RSI indicating potential oversold condition
- Attractive dividend yield with sustainable payout
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Operating margin expansion and earnings growth
- Analyst consensus of strong buy and target price lift
- Undervaluation relative to DCF fair value
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term valuation gap of >20% upside
- Stable cash position and low geographic concentration
- Consistent dividend income supporting total return
Key Metrics & Analysis
Financial Health
Revenue Growth10.70%
Profit Margin23.97%
P/E Ratio15.3
ROE7.24%
ROA0.83%
P/B Ratio1.0
Op. Cash Flow$2.2B
Industry P/E17.4
Technical Analysis
TrendBullish
RSI39.4
Support$55.76
Resistance$68.79
MA 20$62.56
MA 50$62.40
MA 200$52.92
MACDBearish
VolumeIncreasing
Fear & Greed Index80
Valuation
Fair Value$81.38
Target Price$72.80
Upside/Downside23.16%
GradeUndervalued
TypeBlend
Dividend Yield3.16%
Risk Assessment
Beta1.26
Volatility31.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.